(Q21563446)

English

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib

scientific article

  • KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib

Statements

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib (English)
1 reference
Theresa Y Wang
0 references
Gregory J Riely
0 references
Vincent A Miller
0 references
Qiulu Pan
0 references
Maureen F Zakowski
0 references
Robert T Heelan
0 references
January 2005
0 references
2
0 references
e17
0 references
1
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit